[Cell-mediated and humoral immunity in HBS-Ag carriers].
The presence of HBs--Ag in the blood was established in 1.8% of practically healthy persons, in 29.7% of virus hepatitis patients and in 86.0% of serum hepatitis patients. The immunological study of clinically healthy HBs--Ag carriers revealed a statistically significant decrease in the number of T and B lymphocytes and an increased level of serum IgA, IgM and IgG in the blood. Among donors, 7.6% were found to have lymphocytes sensitized to HBs--Ag and 15.4% were found to have lymphocytes sensitized to liver antigen, while for HBs--Ag carriers these data were 62.5% and 50%, respectively.
D000328:Adult; D001402:B-Lymphocytes / Q000276:immunology*; D002353:Carrier State / Q000276:immunology*; D006509:Hepatitis B / Q000276:immunology*; D006514:Hepatitis B Surface Antigens; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D007958:Leukocyte Count; D007961:Leukocyte Migration-Inhibitory Factors / Q000032:analysis; D008099:Liver / Q000276:immunology; D008297:Male; D013601:T-Lymphocytes / Q000276:immunology*
D006514:Hepatitis B Surface Antigens; D007136:Immunoglobulins; D007961:Leukocyte Migration-Inhibitory Factors
Kletochno-oposredovannyĭ i gumoral'nyĭ immunitet u nositeleĭ HBS-Ag.